Harrow to Raise $50M in Senior Unsecured Notes to Fuel Growth Initiatives
Summary
Harrow, Inc. announced an add-on offering of $50.0 million in 8.625% senior unsecured notes due 2030. This financing, which expands on existing notes, is earmarked for general corporate purposes, including accelerating growth initiatives, funding product development, and strategic business development opportunities. This capital raise aligns with the company's recent positive momentum, including strong 2026 financial guidance and reported revenue growth in 2025. While increasing the company's debt, the funds are intended to fuel further expansion in its ophthalmic disease management solutions. Traders should watch for updates on how these proceeds are deployed and their contribution to future revenue and profitability.
At the time of this announcement, HROW was trading at $33.60 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.3B. The 52-week trading range was $20.85 to $54.85. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.